Exeter Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.27M Sell
24,683
-1,242
-5% -$289K 2.4% 10
2026
Q1
$6.34M Sell
25,925
-2,128
-8% -$496K 2.59% 7
2025
Q4
$5.81M Buy
28,053
+364
+1% +$72K 2.47% 9
2025
Q3
$5.13M Sell
27,689
-785
-3% -$134K 2.22% 11
2025
Q2
$4.35M Sell
28,474
-44
-0.2% -$6.76K 1.94% 15
2025
Q1
$4.73M Buy
28,518
+4,417
+18% +$691K 2.12% 13
2024
Q4
$3.49M Sell
24,101
-1,430
-6% -$222K 1.6% 21
2024
Q3
$4.14M Buy
25,531
+455
+2% +$72.5K 1.83% 16
2024
Q2
$3.67M Buy
25,076
+348
+1% +$51.8K 1.75% 18
2024
Q1
$3.77M Buy
24,728
+784
+3% +$125K 1.74% 18
2023
Q4
$3.87M Buy
23,944
+110
+0.5% +$16.9K 1.88% 15
2023
Q3
$3.71M Sell
23,834
-555
-2% -$91.6K 1.96% 15
2023
Q2
$3.87M Sell
24,389
-2,690
-10% -$434K 2% 15
2023
Q1
$4.45M Sell
27,079
-51
-0.2% -$8.23K 2.23% 12
2022
Q4
$4.79M Sell
27,130
-5
-0% -$863 2.5% 8
2022
Q3
$4.43M Buy
27,135
+615
+2% +$104K 2.57% 8
2022
Q2
$4.71M Buy
26,520
+89
+0.3% +$15.9K 2.63% 7
2022
Q1
$4.68M Buy
26,431
+819
+3% +$139K 2.54% 8
2021
Q4
$4.43M Sell
25,612
-3
-0% -$491 2.43% 9
2021
Q3
$4.14M Buy
25,615
+209
+0.8% +$35.7K 2.47% 10
2021
Q2
$4.29M Buy
25,406
+523
+2% +$86.6K 2.49% 10
2021
Q1
$4.09M Buy
24,883
+580
+2% +$93.8K 2.58% 9
2020
Q4
$3.83M Buy
24,303
+214
+0.9% +$31.6K 2.65% 8
2020
Q3
$3.59M Buy
24,089
+143
+0.6% +$21.2K 2.8% 9
2020
Q2
$3.37M Sell
23,946
-19
-0.1% -$2.77K 2.8% 9
2020
Q1
$3.14M Sell
23,965
-567
-2% -$80.4K 2.95% 8
2019
Q4
$3.58M Sell
24,532
-502
-2% -$68.1K 2.78% 10
2019
Q3
$3.24M Sell
25,034
-28
-0.1% -$3.69K 2.58% 12
2019
Q2
$3.49M Buy
25,062
+238
+1% +$32.9K 2.92% 8
2019
Q1
$3.47M Sell
24,824
-147
-0.6% -$19.7K 3% 7
2018
Q4
$3.22M Buy
24,971
+407
+2% +$56.8K 3.04% 6
2018
Q3
$3.39M Sell
24,564
-15
-0.1% -$1.99K 2.79% 9
2018
Q2
$2.98M Sell
24,579
-733
-3% -$91.4K 2.63% 10
2018
Q1
$3.24M Sell
25,312
-270
-1% -$36.5K 2.78% 8
2017
Q4
$3.57M Buy
+25,582
New +$3.56M 3.11% 6

Other funds holding JNJ

Exeter Financial's JNJ Position: Q2 2026 in Review

Exeter Financial reduced its Johnson & Johnson (JNJ) stake by 4.8% in Q2 2026, selling an estimated $289K and leaving 24,683 shares worth $6.27M. The position accounts for 2.4% of the portfolio, ranked #10.

Exeter Financial first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.34M in Q1 2026. 1,981 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Exeter Financial held 24,683 shares of Johnson & Johnson worth $6.27M as of Q2 2026.
  • Exeter Financial sold 1,242 Johnson & Johnson shares in Q2 2026, an estimated $289K.
  • Johnson & Johnson made up 2.4% of Exeter Financial's portfolio in Q2 2026, its #10 holding.
  • Exeter Financial first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • Exeter Financial's Johnson & Johnson position peaked at $6.34M in Q1 2026.
  • 1,981 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.